Vascular Pharmacology

Papers
(The median citation count of Vascular Pharmacology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients86
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis52
Graphical abstract TOC43
Graphical abstract TOC35
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study34
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 10731
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran31
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease28
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies25
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score25
Biobanks: The unmet need in heart failure management24
Animal experimental models of ischemic limbs – A systematic review24
Prevention of cardiovascular complications in elderly cancer patients23
Editorial Board21
Editorial Board21
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes20
A random shuffle method to expand a narrow dataset: A heart failure cohort example20
Diabetes and vascular disease: New therapeutic avenues20
Exploiting endothelial functions in bone regenerative medicine19
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration19
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension18
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model18
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease18
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction18
Lisosan G attenuates doxorubicin-induced injury in HUVEC cells: Antioxidant and sex-dependent autophagic responses17
Short term action potential memory under heart failure conditions: An in silico study17
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets17
Adipsin in the pathogenesis of cardiovascular diseases16
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension16
Hemodynamic markers: CFD-based prediction of cerebral aneurysm rupture risk15
Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes15
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis14
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis14
Circulating osteonectin predicts postural imbalance and cardiac dysfunction in heart failure14
Graphical abstract TOC14
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro14
Graphical abstract TOC14
Targeting the Ca2+ signaling toolkit as an alternative strategy to mitigate SARS-CoV-2-induced cardiovascular adverse events14
The choice of the computational model impacts on the effects of the HCM-related MYBPc3 c772G->A mutation13
Contents continued13
Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)13
Novel NLRP3 inflammasome inhibitors INF150 and INF195 attenuate isoproterenol-induced hypertrophy in H9c2 rat cardiac myoblast13
Sodium nitroprusside: A comprehensive systematic review of its role across various clinical settings12
Trimethylamine N-oxide (TMAO) impact on endothelial dysfunction: An in vitro study using bovine aortic endothelial cells12
Myocardial energy balance and metabolism as causes of myocardial ischemia12
Therapeutic perspective on cardiomyopathy and heart failure in older adults through the lens of chronic inflammation12
Brain natriuretic peptide as a potential predictor of hemorrhagic transformation in acute ischemic stroke patients with successful endovascular recanalization: A two-center retrospective cohort study12
The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis12
Corrigendum to “Non-coding RNAs regulate angiogenic processes” [Vascular pharmacology 133–134 (2020) 106778]12
The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension12
Additional therapeutic benefits of H2S-Donor combined with Dapagliflozin in a model of heart failure with preserved ejection fraction (HFpEF)12
Interplay between CD28 and PD-1 in T cell immunotherapy12
Graphical abstract TOC12
Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment12
Dynamic co-culture of endothelial and smooth muscle cells as a platform for pathophysiological investigations of vascular calcifications12
Sexual dimorphism in aortic aneurysm: A review of the contributions of sex hormones and sex chromosomes11
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice11
Inflammation and the pathogenesis of atherosclerosis11
Clinical characteristics and five-year outcomes in a prospective Russian real-world heart failure cohort11
3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study11
Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials11
Editorial Board11
A treatment algorithm for ischemic cardiomyopathy10
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction10
Roles of endothelial and smooth muscle cell dysfunction and vasa vasorum in vasomotor disorders in ischemia with no obstructive coronary artery disease10
The influence of environmental hypoxia on the goldfish (Carassius auratus) heart: From functional responses to mitochondrial molecular mechanisms10
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment10
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques10
Effects of simvastatin treatment on leptomeningeal collateral vessels: resistance, number and diameter10
Zinc alpha 2-glycoprotein associates with features of plaque stability in patients with carotid atherosclerosis10
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets10
Relevance of real-time analyzers to determine mitochondrial quality in endothelial cells and oxidative stress in preeclampsia10
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human10
Empagliflozin protects H9c2 cardiomyoblasts from lipid-induced stress9
Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteries9
Immune response following transcatheter aortic valve procedure9
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid9
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)9
The chemokine receptor CXCR4 and its ligand CXCL12 (SDF-1) localize to ependymal cilia in brain ventricles9
Cardiolipins dynamics during h-iPSC cardiomyocytes differentiation and end-stage failing heart condition9
Secondary multifactorial thrombotic microangiopathy revealing advanced HIV infection: A case report on endothelial dysfunction and estrogen therapy8
Plasma exosomes after PCI in non-diabetic STEMI patients fed barley beta-D-glucan-enriched pasta reduce oxidative stress-induced endothelial cell senescence8
CaMKIIδ splice variants differentially regulate vascular smooth muscle cell motility8
Editorial Board8
Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??8
Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice8
Advancements in non-invasive hyperspectral imaging: Mapping blood oxygen levels and vascular health for clinical and research applications8
Graphical abstract TOC8
The selective deletion of tyrosyne hydroxylase gene in the endothelium affects cardiovascular function8
Multi-omics identification of quantitative trait loci associated with vascular pathogenesis and diagnostic potential in chronic venous disease8
PI3KC2α: A novel key player in cardiac contractility and DOX-induced cardiotoxicity?8
The role of the endothelium in long COVID8
Amyloid-β: A potential mediator of aging-related vascular pathologies8
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions8
Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study8
Catestatin as a key attenuator of cardiac inflammation in hypertension: Role of macrophage immunosuppression8
N6-methyladenosine (m6A) post-transcriptional modification regulation of mRNA, an overlooked therapeutic opportunity to leverage mRNA processing in vascular smooth muscle cells8
MELAS syndrome: Insights into cardiac mechanics8
Graphical abstract TOC7
Graphical abstract TOC7
Editorial Board7
A new perspective on lipid metabolism regulation to promote cardiac resilience to stress7
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles7
Untargeted metabolomic profiling reveals mTORC1-dependent regulation of amino acid utilization in lymphatic endothelial cells7
From cine-MRI to computational models of blood flow within the heart7
Extracellular stiffness as a determinant of cardiac dysfunction in Duchenne's muscular dystrophy: A study on human iPSC-derived cardiomyocytes7
Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease7
iPSC-derived cardiac models for exploring MLIP function in LMNA cardiomyopathy7
Matrix metalloproteinases in aortic dissection7
Sodium nitroprusside for advanced heart failure. A metanalysis of literature data7
Effects of mavacamten in human myocardium from hypertrophic obstructive cardiomyopathy (HOCM) patients: A comparison with disopyramide7
Is remote conditioning cardioprotection temperature dependent?7
Stay connected: The myoendothelial junction proteins in vascular function and dysfunction7
The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies7
Emerging role of the adaptive immunity in aortic aneurysm and dissection6
Graphical abstract TOC6
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms6
Development of an AI-based algorithm designed to model and predict temporal dynamics of heart rate variability (HRV)6
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging6
Emerging therapies in dyslipidaemias6
Takotsubo: Profiling extracellular vesicles to reveal pathophysiology6
Wavelet spectral analysis of microvascular blood flow during nociceptive and cognitive stimuli6
Statin-mediated regulation of miRNA expression in circulating endothelial progenitor cells in hypertensive patients: A translational mechanism of vascular protection6
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling6
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death6
Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm6
An intrinsic mechanism of metabolic resilience influences the cardiac response to stress5
Telomere dysfunction, vascular aging, and acute coronary syndrome: Clinical insights and the role of PM10 exposure5
An AI and Statistical Shape Analysis combined framework to extract features in complex cardiovascular structures5
Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability5
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function5
Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing5
Contents continued5
Platelet modulation in cardiac ischemia/reperfusion injury: Functional impact of ADP, high glucose and NLRP3 inhibition5
Graphical abstract TOC5
The crosstalk between lipopolysaccharide-induced septic myocardial dysfunction and cardiac lipotoxicity: Toll like receptor 4 as common target of the novel cardioprotective peptide cateslytin4
Myocardin related transcription factor and galectin-3 drive lipid accumulation in human blood vessels4
Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease4
Explosive discovery, surprising future: The extraordinary journey of nitroglycerin, nitroderivatives and nitric oxide4
Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches4
Palmitate-induced cardiac lipotoxicity is relieved by Quercetin and its novel acetylated derivative Q2 through inhibition of oxidative stress and inflammation4
Graphical abstract TOC4
Assessing the impact of air pollution on human embryonic cardioids using innovative longitudinal monitoring and machine learning4
The pathophysiology of heme in the vascular system4
Endothelial-to-mesenchymal transition gene signature derived from single-cell transcriptomics of human atherosclerotic tissue associates with stable plaque histological characteristics4
Macrophages release miRNAs in response to Doxorubicin with a potential role in indirect cardiac damage4
LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell4
Emerging effects of non-coding RNA in vascular endothelial cells during strokes4
Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease4
Chronic venous insufficiency and cardiovascular risk: Marker or bystander?4
Engineering functional human vasculature: iPSC-derived vascular cells and organoids for disease modeling and translation4
Understanding the pathobiology of intermediate filaments to curb acute and chronic cardiac dysfunction4
Plaque histological characteristics in individuals with sudden coronary death3
Prolonged L-NAME exposure changes the vasodilator factor from NO to H2O2 in human arterioles in response to A231873
The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function – A systematic review3
17β-Estradiol-mediated modulation of Notch1 in murine macrophage cell line RAW 264.73
N-glycosylation signature and its relevance in cardiovascular immunometabolism3
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification3
The hydroxamic acid derivative YPX-C-05 alleviates hypertension and vascular dysfunction through the PI3K/Akt/eNOS pathway3
Association of serum 25-hydroxyvitamin D3 levels with carotid artery intima-media thickness and carotid atherosclerotic plaques in smokers3
Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 23
Antibody-mediated PCSK9 neutralization worsens outcome after bare-metal stent implantation in mice3
Vasorelaxant effects of 3-methoxycatechol are not via direct activation of voltage-gated potassium channels3
Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: Novel targets for therapy3
Right Ventricular-Pulmonary Arterial Coupling and Exercise-induced Pulmonary Congestion in Heart Failure with Reduced and Mildly-reduced Ejection Fraction3
Local hemodynamics effects of ischemic preconditioning on non-fatiguing voluntary contractions3
Functional characterization of human IL-8 in vascular stenosis using a novel humanized transgenic mouse model3
Doxycycline induces mitochondrial dysfunction in aortic smooth muscle cells3
Graphical abstract TOC3
Long-term effects of regular intake of barley beta glucan-containing pasta on left ventricular function in non-diabetic STEMI patients: The Cuore Sano study3
Mediterranean G6PD variant rats are protected from Angiotensin II-induced hypertension and kidney damage, but not from inflammation and arterial stiffness3
Macrophages participate in doxorubicin-induced cardiac damage3
Editorial Board3
RNA-seq and ChIP-seq reveal microplastics induce endothelial-mesenchymal transition via HK2-mediated histone lactylation in pulmonary hypertension3
Studying exosome fingerprint in COVID 19 patients using MALDI-TOF3
Mitochondria-rich endothelial vesicles safeguard cardiomyocytes from doxorubicin injury in vitro3
Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury3
The role of sinoatrial node heterogeneity in atrial driving and arrhythmia3
Retraction notice to “Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis” [Vascular Pharmacology 113 (2019) 86-91]2
Targeting Cis-regulatory elements for CRISPR-mediated transcriptional activation of the human MIR503HG locus2
Immunometabolic and vasoprotective effects of “Aglianico del Vulture” red wine polyphenols in human endothelial cells and spontaneously hypertensive rats2
Efficacy and safety of tirofiban in patients with acute ischemic stroke treated with endovascular thrombectomy: A frequentist and Bayesian meta-analysis2
In-vitro studies of the NaV1.5 S805L Brugada mutation: The resting cell voltage is a critical element in determining the pathological or physiological phenotype of the current2
Intracellular Ca2+ dynamics modulation by istaroxime and its metabolite in pulmonary artery smooth muscle cells2
Inferior vena cava filters: Concept review and summary of current guidelines2
An X-ray computed μ-tomography analysis for the characterization of 3D-heart shape in a model of cardiac plasticity2
Sex differences in vascular endothelial function related to acute and long COVID-192
Graphical abstract TOC2
Characterization of the PLN-R14Del mutation in hiPSC-derived cardiomyocytes2
Sex-based variability in cardiac electromechanical properties: Insights into arrhythmia susceptibility and protection2
Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy2
Unvealing organ-specific endothelial heterogeneity and its dysfunction2
Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries2
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis2
Unraveling the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy2
Comment on “Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteries” [Lubomirov et al., Vascular pharmacology 160 (2025) 107515]2
The new role of Tryptophan 2,3- dioxygenase in modulating human endothelial cell and endothelial precursor functions2
Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines2
Graphical abstract TOC2
Percutaneous coronary interventions versus coronary artery bypass graft surgery in coronary artery disease2
Contents continued2
Assessing the peripheral effect of ischemic preconditioning using electrically-stimulated contraction of the adductor pollicis2
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis2
Prestroke barley beta-D-glucan supplementation protects heart and brain from consequences of ischemic stroke regardless of caloric restriction2
The effect of drugs and stem cell therapies on established abdominal aortic aneurysms in mice: A systematic review and meta-analysis2
Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study2
Video analysis of ex-vivo beating hearts during preservation on the TransMedics® organ care system2
Electrophysiological remodeling in primary versus secondary cardiac hypertrophy: A study in human cardiomyocytes2
Advances and limitations in angiogenesis assays: Integrating in vitro, in vivo, and emerging technologies2
Impaired endothelial function in duchenne muscular dystrophy-associated cardiomyopathy: Insights from hiPSC-derived endothelial cells2
Patient-specific iPSC models as predictors of therapeutic response in TTN-related dilated cardiomyopathy2
Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosis2
Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells2
Sex-related differential susceptibility to ponatinib-induced cardiotoxicity and its relationship to modulation of Notch signaling in a murine model2
Chronic thromboembolic disease: Association with exercise-induced pulmonary hypertension and right ventricle deterioration2
The use of glycoprotein IIb/IIIa inhibitors in elective PCI – A systematic review and meta-analysis of randomised trials1
Population of models and cross-phenotype translators approaches to stratify hypertrophic cardiomyopathy mutations1
Organ-specific model of simulated ischemia/reperfusion and hyperglycemia based on engineered heart tissue1
The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project1
Intraoperative detection of exosomal proteins associated with cancer risk in older cardiac surgery patients without a history of malignancies1
The chromogranin A1-373 fragment exerts strong cardioregulatory effects by engaging neuropilin-1 through minimal changes in the protein sequence1
Graphical abstract TOC1
Quinazoline-based human phosphodiesterase 5 inhibitors exhibited a selective vasorelaxant effect on rat isolated pulmonary arteries involving NO-sGC-cGMP pathway and calcium inhibitory effects1
Trends in colchicine use across the spectrum of coronary artery disease1
Generation and phenotyping of a novel knock-in mouse model of Desmoplakin- dependent arrhythmogenic cardiomyopathy1
PI3KC2α controls cardiac contractility through regulation of β2-adrenergic receptor recycling1
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact1
The role of Epsins in atherosclerosis: From molecular mechanisms to therapeutic applications1
Graphical abstract TOC1
The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathway1
Endostatin in disease modulation: From cancer to beyond1
Inhaled argon as a neuroprotective agent after an ischemic event – a fully translational story from animal studies to a human trial1
The pharmacological modulation of PPAR- γ as therapeutic strategy in the failure of arteriovenous fistula1
Graphical abstract TOC1
Emerging role of mesenchymal cells in cardiac and cerebrovascular diseases: Physiology, pathology, and therapeutic implications1
Contents continued1
Graphical abstract TOC1
Contents continued1
Nanocarrier-based drug delivery strategies for Raynaud's phenomenon: Overcoming microvascular and perfusion barriers1
Ion channels of the human heart: A comprehensive four-chamber analysis1
A slower beat: Aglianico grape pomace extract as a novel modulator of cardiac rhythmicity1
COVID-19 plasma induces subcellular remodelling within the pulmonary microvascular endothelium1
The pleiotropic effects of sotatercept1
Editorial Board1
Reduction of doxorubicine-induced senescence does not provide cardioprotective effect in mice1
Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension1
Proteomics analysis on aortic smooth muscle cells reveals new potential targets for the treatment of Marfan syndrome-associated thoracic aortic aneurysm1
Protective effects of Salvia Haenkei extract on a model of Doxorubicin-induced cardiotoxicity1
Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching1
A critical appreciation of pathway analysis in atherosclerotic disease. Cellular phenotypic plasticity as an illustrative example1
0.46500492095947